Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease

ABSTRACT Cardiac laminopathies, associated with mutations in the LMNA gene, encompass a wide spectrum of clinical manifestations, involving electrical and mechanical alterations of cardiomyocytes. Thus, dilated cardiomyopathy, bradyarrhythmias and atrial or ventricular tachyarrhythmias may occur in a number of combined phenotypes. Nowadays, some attempt has been made to identify clinical predictors for the most life-threatening complications of LMNA-associated heart disease, i.e. sudden cardiac death and end-stage heart failure. The goal of this manuscript is to combine the most recent evidences in an updated review to show the state-of-the-art of such a complex disease group. This is supposed to be the starting point to collect more data and design new ad hoc studies to identify clinically useful predictors to stratify risk in mutation carriers, including probands and their asymptomatic relatives.

[1]  M. Care,et al.  Genetic Testing in Inherited Heart Diseases: Practical Considerations for Clinicians , 2017, Current Cardiology Reports.

[2]  W. Tang,et al.  Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies , 2017, Current Treatment Options in Cardiovascular Medicine.

[3]  Hyun-Young Park Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic Diagnostics , 2017, Korean circulation journal.

[4]  P. Piirilä,et al.  Clinical disease presentation and ECG characteristics of LMNA mutation carriers , 2017, Open Heart.

[5]  W. Stevenson,et al.  Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers. , 2016, Journal of the American College of Cardiology.

[6]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[7]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[9]  L. Maggi,et al.  Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features , 2016, Cells.

[10]  W. Stevenson,et al.  Multicenter Experience With Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy , 2016, Circulation. Arrhythmia and electrophysiology.

[11]  R. Hershberger,et al.  LMNA-Related Dilated Cardiomyopathy , 2016 .

[12]  C. Simone,et al.  Clinical and Functional Characterization of a Novel Mutation in Lamin A/C Gene in a Multigenerational Family with Arrhythmogenic Cardiac Laminopathy , 2015, PloS one.

[13]  Claudio Passino,et al.  Markers of fibrosis, inflammation, and remodeling pathways in heart failure. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[14]  E. Bertini,et al.  LMNA-associated myopathies , 2014, Neurology.

[15]  T. Edvardsen,et al.  Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[17]  D. Hedges,et al.  Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.

[18]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[19]  A. Anastasakis,et al.  A patient with ventricular tachycardia due to a novel mutation of the lamin A/C gene: case presentation and mini review. , 2013, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[20]  L. Maggi,et al.  Overlapping syndromes in laminopathies: a meta-analysis of the reported literature , 2013, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[21]  I. Hausmanowa-Petrusewicz,et al.  Advances in basic and clinical research in laminopathies , 2013, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[22]  G. Bonne,et al.  ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.

[23]  B. Kennedy,et al.  Phosphorylation of connexin43 on S279/282 may contribute to laminopathy-associated conduction defects. , 2013, Experimental cell research.

[24]  A. Zwinderman,et al.  Gender‐specific differences in major cardiac events and mortality in lamin A/C mutation carriers , 2013, European journal of heart failure.

[25]  E. Rampersaud,et al.  Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. , 2013, Journal of cardiac failure.

[26]  P. Golino,et al.  Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patients , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[27]  S. Adam,et al.  Nuclear lamin functions and disease. , 2012, Trends in genetics : TIG.

[28]  Richard L. Frock,et al.  Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna −/− Mice , 2012, PloS one.

[29]  A. Zwinderman,et al.  Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications. , 2013, International journal of cardiology.

[30]  E. Arbustini,et al.  What Should the Cardiologist know about Lamin Disease? , 2012, Arrhythmia & electrophysiology review.

[31]  M. Ashworth,et al.  Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. , 2012, European heart journal.

[32]  A. Zwinderman,et al.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.

[33]  S. Sideris,et al.  Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part I: malignant ventricular arrhythmias. , 2011, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[34]  P. Golino,et al.  P-Wave Duration and Dispersion in Patients With Emery-Dreifuss Muscular Dystrophy , 2011, Journal of Investigative Medicine.

[35]  K. Wahbi,et al.  N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations. , 2011, International journal of cardiology.

[36]  Jonathan T. Lu,et al.  LMNA cardiomyopathy: cell biology and genetics meet clinical medicine , 2011, Disease Models & Mechanisms.

[37]  J. Lötjönen,et al.  Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[38]  Pamela K. Mason,et al.  Lamin A/C deficiency as a cause of familial dilated cardiomyopathy , 2009, Current opinion in cardiology.

[39]  L. Tavazzi,et al.  Long-term outcome and risk stratification in dilated cardiolaminopathies. , 2008, Journal of the American College of Cardiology.

[40]  Michael Jerosch-Herold,et al.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[41]  I. V. Van Gelder,et al.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. , 2007, American heart journal.

[42]  E. Bertini,et al.  Phenotypic clustering of lamin A/C mutations in neuromuscular patients , 2007, Neurology.

[43]  Y. Pinto,et al.  Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene. , 2007, Journal of the American College of Cardiology.

[44]  S. Young,et al.  Mouse models of the laminopathies. , 2007, Experimental cell research.

[45]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[46]  R. Hetzer,et al.  Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A/C mutant carriers , 2006, European journal of heart failure.

[47]  U. Nellessen,et al.  Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy , 2006, Clinical cardiology.

[48]  J. Cleland,et al.  Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study. , 2006, International journal of cardiology.

[49]  V. Hombach,et al.  Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy , 2006, European journal of heart failure.

[50]  Y. Pinto,et al.  Primary prevention of sudden death in patients with lamin A/C gene mutations. , 2006, The New England journal of medicine.

[51]  M. Laakso,et al.  Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy , 2005, Heart.

[52]  F. Tezuka,et al.  Electrophysiological and Histopathological Characteristics of Progressive Atrioventricular Block Accompanied by Familial Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene , 2005, Journal of cardiovascular electrophysiology.

[53]  Y. Pinto,et al.  Often seen but rarely recognised: cardiac complications of lamin A/C mutations. , 2004, European heart journal.

[54]  L. Tavazzi,et al.  Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects , 2003, Virchows Archiv.

[55]  L. Mestroni,et al.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. , 2003, Journal of the American College of Cardiology.

[56]  Eloisa Arbustini,et al.  Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. , 2002, Journal of the American College of Cardiology.

[57]  B. Eymard,et al.  High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation , 2000, Pacing and clinical electrophysiology : PACE.

[58]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[59]  D. Levy,et al.  Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. , 1997, Circulation.

[60]  H. Worman,et al.  Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. , 1993, The Journal of biological chemistry.

[61]  J. Ryan,et al.  Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. , 1986, Circulation.

[62]  K. Stephens,et al.  LMNA-Related Dilated Cardiomyopathy -- GeneReviews® , 2016 .

[63]  T. Edvardsen,et al.  Mechanical dispersion by strain echocardiography: a predictor of ventricular arrhythmias in subjects with lamin A/C mutations. , 2015, JACC. Cardiovascular imaging.

[64]  Andrea Mazzanti,et al.  [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.

[65]  J. Nielsen,et al.  ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .

[66]  M. Emdin,et al.  CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. , 2013, JACC. Cardiovascular imaging.

[67]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[68]  B. Funke,et al.  Dilated cardiomyopathy , 2007, Archives of Disease in Childhood.

[69]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[70]  T. Calvo,et al.  Ac ce pte d m an us cri pt Aggregation functions based on penalties , 2010 .

[71]  S. Raman,et al.  Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[72]  H. Crijns,et al.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.